BMS investors voice discontent over $74bn Celgene deal
BMS has been struck a blow in its plans to acquire Celgene, after its largest investor questioned the risk of the deal.
BMS has been struck a blow in its plans to acquire Celgene, after its largest investor questioned the risk of the deal.
SCOPE 2019
Alphabet's research organization Verily is on a mission to empower patients with their own data – and to collectively solve some of the industry’s biggest challenges, says SCOPE keynote speaker.
Clinerion is expanding access to international clinical studies with the help of the Georgian medical software company, Medsoft.
Houston Methodist Hospital joins the TriNetX global health research network to provide RWD for study feasibility and academic collaboration in industry-sponsored clinical trials.
Sharing clinical trial and research data for rare diseases is imperative for drug development and disease understanding, says industry expert.
SCOPE 2019
Artificial intelligence works best in a standardized environment, say industry experts. Workflows and processes must first be aligned to successfully use the technology – is pharma ready?